On August 14th, Dr Tedros Adhanom Ghebreyesus, director-general of the World Health Organization , declared the mpox outbreak a public health emergency of international concern .
Unlike mRNA vaccines, Jynneos follows the traditional vaccine model, coming from the modified vaccinia Ankara strain that is disabled from replicating in human cells. Aimed at both smallpox and monkeypox , Bavarian Nordic began to commercially roll out Jynneos this April. For the mpox demand, Bavarian Nordic expects up to $445 million revenue in 2024, of which just over half is from government contracts. Year-to-date, BVNRY stock is up 51%, currently priced at $13.39 against the 52-week low of $5.95 and high of $14.74 per share.This Maryland biopharma company developed ACAM2000 live vaccine, first FDA-approved in August 2007 for smallpox. Having been deemed as superior to Dryvax, ACAM2000 replaced it for the US Strategic National Stockpile.
The firm’s Narcan nasal spray sales comprised the bulk of the revenue at $120 million out of total $183.4 million in sales, representing a 10% decline vs the year-ago quarter. Presently priced at $11.38, EBS stock is nearly 3x against the 52-week average of $4.06, but still under its 52-week high of $15.10 per share.) is a prospective mpox exposure.
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Investingcom - 🏆 450. / 53 Read more »